McKesson (NYSE:MCK) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
McKesson (NYSE:MCK) had its "buy (a-)" rating reaffirmed by analysts at
Weiss Ratings.
Mazdutide 9 mg Achieves Up to 20.1% Weight Loss in Chinese Adults with Obesity, GLORY-2 Study Meets Primary and All Key Secondary Endpoints [Yahoo! Finance]
McKesson Corporation (MCK) Strong Quarter Spurs Analyst Confidence [Yahoo! Finance]
McKesson (NYSE:MCK) had its "buy (b+)" rating reaffirmed by analysts at
Weiss Ratings.